Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Healthy Older Adults
NCT07516405Phase 1Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Apr 2026
- Primary completion
- Mar 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of psilocybin (2 cohorts), sponsored by University of Colorado Denver. Primary endpoint: Adverse Events at 14 weeks. Started Apr 2026; status: recruiting.
02
Drugs
psilocybin
Beyond the preview
Go deeper on NCT07516405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07516405.